Alteco endotoxin hemoadsorption in Gram-negative septic shock patients. Ind J Crit Care Med 2014;18:783-788
Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 1997;112:235-43.
Endotoxemia and Endotoxin Shock: Disease, Diagnosis and Therapy. Contrib Nephrol. Vol. 167. Basel: Karger; 2010.
Early use of polymyxin B hemoperfusion in abdominal septic shock: The EUPHAS randomized controlled trial. JAMA 2009;301:2445-52.
A new endotoxin adsorption device in Gram-negative sepsis: Use of immobilized albumin with the MA.TISSE adsorber. Transfus Apher Sci 2003;29:93-8.
A new endotoxin adsorber in septic shock: Observational case series. Blood Purif 2011;32:303-9.
Treatment of septic shock with continuous HDF using 2 PMMA hemofilters for enhanced intensity. Int J Artif Organs 2012;35:3-14.
Polymyxin B-immobilizrd fiber hemoprtfusion in patients with sespsis. Dial Transplant 2003;32:602-7.
Estimation of efficacy early selective LPS sorption in patients with septic shock. Crit Care 2012;16 Suppl 3:75.
Polymyxin B hemoperfusion in clinical practice: The picture from an unbound collaborative registry. Blood Purif 2014;37 Suppl 1:22-5.
The EUPHRATES trial (evaluating the use of polymyxin B hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock): Study protocol for a randomized controlled trial. Trials 2014;15:218.
